ID   MYE 2004
AC   CVCL_E788
DR   dbMHC; 48982
DR   IHW; IHW09420
DR   IPD-IMGT/HLA; 26024
DR   Wikidata; Q54907171
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*29:02:01:01,68:18N; B*14:02:01,57:01:01; C*06:02:01:01,08:02:01:01; DPA1*01:03:01:03; DPB1*02:01:02,06:01; DQA1*02:01,05:05:01:02; DQB1*03:01:01:03,03:03:02:01; DRB1*07:01:01,13:03:01; DRB3*01:01:02:01; DRB4*01:03:01:02N (IPD-IMGT/HLA=26024).
CC   HLA typing: A*29:02:01:01,68:18N; B*14:02:01:01,57:01:01; C*06:02:01:01,08:02:01:01; DPA1*01:03:01:01,01:03:01:03; DPB1*02:01:02,06:01:01; DQA1*02:01:01,05:05:01; DQB1*03:01:01:03,03:03:02:01; DRB1*07:01:01,13:03:01; DRB3*01:01:02; DRB4*01:03:01:02N (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//